All Legal

Image for article 235971

EC approves takeover

Andrew McClean reports on the conditions detailed in the European Commission’s review of the proposed takeover

Image for article 234942

Seven Ways: Minimising contact

Bill Harvey speaks to Mike Hale about seven ways to use instruments, equipment and software to help minimise patient contact time in practice and keep as much distance between patients and staff as possible

Image for article 227385

In Focus: Phased reopening

Yiannis Kotoulas examines the new NHS Wales advice on how practices should implement social distancing once they re-open

Image for article 226389

Post-pandemic manifesto

A manifesto for the future of eye care services has been launched in anticipation of a backlog of patients requiring treatment after coronavirus. Andrew McClean reports on how the AIO thinks primary care optometry can help

Image for article 225198

Multiple responds to Radio 4

A recent Radio 4 consumer report claimed Optical Express patients felt pressured into having procedures. Andrew McClean looks at the fake news fall out

Image for article 221872

Drivers’ vision regulation

Yiannis Kotoulas reports on the optical profession’s call for more rigorous driving eyesight rules during Road Safety Week

Image for article 218330

Compulsory eye tests

Zoe Wickens reports on the latest government road safety statement which has been broadly welcomed by optical professional bodies

Image for article 216788

GDPR one year on

GDPR has been with us for over a year now. Ann Bevitt outlines the key aspects to look out for as enforcement is ramped up

Image for article 189850

Avastin ruling

A ruling in favour of 12 CCGs is an important win for AMD sufferers and the health service, reports Sean Rai-Roche

Image for article 143900

The Honey Rose trial fallout

Widespread media coverage of the tragic death of a young patient following a missed referral has left its mark on the profession, despite his parents’ wish not to damage the reputation of optometrists. Joe Ayling reports on the continued fallout from a landmark trial for the profession and wider medical sector